Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
HERITAGE PHARMACEUTICALS INC. v. GLAZER et al
Case Number:
3:16-cv-08483
Court:
Nature of Suit:
Racketeer/Corrupt Organization
Judge:
Firms
Companies
Sectors & Industries:
-
July 24, 2019
Heritage Pharma, Former Execs Reach Deal In RICO Suit
Heritage Pharmaceuticals Inc. has resolved its Racketeer Influenced and Corrupt Organizations Act suit against two former executives, a deal that comes on the heels of the company's separate agreements with federal prosecutors over price-fixing claims, according to an order filed Wednesday in New Jersey federal court.
-
November 14, 2018
Gibson Dunn Bows Out Of Pharma RICO Suit Amid DQ Bid
Gibson Dunn & Crutcher LLP has withdrawn as counsel for Heritage Pharmaceuticals Inc. in the company's Racketeer Influenced and Corrupt Organizations Act suit against two former executives amid their pending motions to disqualify the firm over its prior ties to them, according to a letter sent by co-counsel to a New Jersey federal judge.
-
March 22, 2018
Gibson Dunn DQ Sought By Ex-Pharma Execs In RICO Suit
Two former Heritage Pharmaceuticals Inc. executives urged a New Jersey federal court Wednesday to disqualify Gibson Dunn & Crutcher LLP as counsel for the company in its Racketeer Influenced and Corrupt Organizations Act suit alleging the men siphoned millions from the business, with the reasons for the disqualification bids filed under seal.
-
December 14, 2016
DOJ Charges 2 Execs In Generic Drug Price-Fixing Plot
The U.S. Department of Justice on Wednesday accused the former top executives of Heritage Pharmaceuticals of plotting to fix prices of antibiotics and diabetes treatments, marking the first charges in the watchdog's criminal probe of the generic drug industry.